In Vitro Diagnostics Business Outlook: Volume 2, Issue 4 - Clinical Chemistry

6 Jan 2023

Categories:

A monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:

• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage

Table of Contents

Market Analysis: Clinical Chemistry
- Overview of Clinical Chemistry Market
- Market Outlook
  - Major Product Activity
- Regional Market
- Top Company Briefs
  - Roche
  - Abbott
  - Danaher
Executive News Briefing
- Briefs
  - QuidelOrtho Makes Changes in Leadership
  - Roche Appoints New President and CEO of Roche Diagnostics N.A.
  - Senzo Captures $1.9 Million in Additional Funding
Financial Highlights: Chembio Diagnostics, Guardant Health & Veracyte
Diagnostic Market Mergers, Acquisitions and Partnership Deals
- Selected Partnerships and Collaborations
- Mergers and Acquisitions
Industry Watch
- COVID-19 Update
Region Watch
- Croatia
- Egypt
- Sweden
Broad-based Company Announcements
- Announcements
  - Roche Receives Clearance for Two Alzheimer’s Assays
  - BioGX Launches Pixl Portable qPCR Platform Ex-US Expanded
  - Thermo Fisher Scientific Receives De Novo Classification
  - Dexcom Gains Clearance for G7 CGM
  - Agilent Secured Approval for CDx

Attachments

In Vitro Diagnostics Business Outlook Volume 2, Issue 4.pdf